AVTX
#2490
Avalo Therapeutics, Inc. - Common Stock
18.5 5 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.71%
Monthly Change
+28.73%
6 month change
+26.71%
Year Change
+278.57%
Previous Close
18.4 2
Open
18.5 5
Low
18.5 5
High
18.5 5
Volume
128
Financials
- Market Capitalization 975.09 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.avalotx.com
- Headquarter Delaware, United States
- FIGI BBG001QHW0Y8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.68
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2486 |  JANX Janux Therapeutics, Inc. - Common Stock | 16.03 USD | +1.58% | -3.20% | +16.41% | -41.04% | 977.58 M USD | ||
| 2487 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.20 USD | +3.77% | -3.51% | +12.82% | +69.23% | 977.23 M USD | ||
| 2491 |  ANRO Alto Neuroscience, Inc. Common Stock | 27.76 USD | -0.29% | +4.48% | +27.69% | +920.59% | 974.21 M USD | ||
| 2510 |  SLDB Solid Biosciences Inc. - Common Stock | 9.62 USD | -0.10% | -12.31% | +35.30% | +68.77% | 947.09 M USD |
Frequently asked questions about Avalo Therapeutics, Inc. - Common Stock
What is the Avalo Therapeutics, Inc. - Common Stock stock price today?
The current price of Avalo Therapeutics, Inc. - Common Stock (AVTX) is 18.55. Over the past 24 hours, the stock has changed by +0.71%. Follow the AVTX chart for real-time price dynamics.
What is the stock ticker of Avalo Therapeutics, Inc. - Common Stock?
Avalo Therapeutics, Inc. - Common Stock trades under the ticker AVTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Avalo Therapeutics, Inc. - Common Stock stock going up?
AVTX has changed by -3.39% over the last week, +28.73% over the last month, and +278.57% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Avalo Therapeutics, Inc. - Common Stock net income for the last quarter?
Avalo Therapeutics, Inc. - Common Stock reported net income of -19.63 M for the last quarter. The previous quarter showed -13.72 M, which means net income changed by -43.08%.
How many employees does Avalo Therapeutics, Inc. - Common Stock have?
As of the latest available data, Avalo Therapeutics, Inc. - Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Avalo Therapeutics, Inc. - Common Stock stock?
You can buy Avalo Therapeutics, Inc. - Common Stock (AVTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Avalo Therapeutics, Inc. - Common Stock stock?
Investing in Avalo Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AVTX chart and related analysis on metatrader.com as part of your research.